PubMed

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.

van Wijk JP, de Koning EJ, Cabezas MC, op't Roodt J, Joven J, Rabelink TJ, Hoepelman AI.

Ann Intern Med. 2005 Sep 6;143(5):337-46. Erratum in: Ann Intern Med. 2005 Nov 1;143(9):695. Dosage error in published abstract; MEDLINE/PubMed abstract corrected. PMID: 16144892 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. HIV lipodystrophy: rosiglitazone or metformin?

[No authors listed]

Ann Intern Med. 2005 Sep 6;143(5):I38. No abstract available. PMID: 16144888 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.

Hadigan C, Yawetz S, Thomas A, Havers F, Sax PE, Grinspoon S.

Ann Intern Med. 2004 May 18;140(10):786-94.PMID: 15148065 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

Hadigan C, Corcoran C, Basgoz N, Davis B, Sax P, Grinspoon S.

JAMA. 2000 Jul 26;284(4):472-7.PMID: 10904511 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.

Silic A, Janez A, Tomazic J, Karner P, Vidmar L, Sharma P, Maticic M.

Croat Med J. 2007 Dec;48(6):791-9.PMID: 18074413 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.

Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S.

AIDS. 2007 Jan 2;21(1):47-57.PMID: 17148967 [PubMed - indexed for MEDLINE]Related articles

Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.

Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P.

Diabetes Care. 2003 Jul;26(7):2069-74.PMID: 12832315 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.

Kohli R, Shevitz A, Gorbach S, Wanke C.

HIV Med. 2007 Oct;8(7):420-6.PMID: 17760733 [PubMed - indexed for MEDLINE]Related articles

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.

Hadigan C, Meigs JB, Rabe J, D'Agostino RB, Wilson PW, Lipinska I, Tofler GH, Grinspoon SS; Framingham Heart Study.

J Clin Endocrinol Metab. 2001 Feb;86(2):939-43.PMID: 11158071 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

Virtanen KA, Hällsten K, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, Lönnroth P, Nuutila P.

Diabetes. 2003 Feb;52(2):283-90.PMID: 12540598 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384. PMID: 10755495 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.

Antivir Ther. 2008;13(1):67-76.PMID: 18389900 [PubMed - indexed for MEDLINE]Related articles

Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.

Kovacic JC, Martin A, Carey D, Wand H, Mallon PW, Feneley MP, Emery S, Cooper DA, Carr A; ROSEY Investigators.

Antivir Ther. 2005;10(1):135-43.PMID: 15751771 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H.

Antivir Ther. 2003 Jun;8(3):199-207.PMID: 12924536 [PubMed - indexed for MEDLINE]Related articles

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.PMID: 16882108 [PubMed - indexed for MEDLINE]Related articles

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.

Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H.

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E941-9. Epub 2004 Jan 28.PMID: 14749206 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H.

Diabetes. 2004 Aug;53(8):2169-76.PMID: 15277403 [PubMed - indexed for MEDLINE]Related articlesFree article

Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.

Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A.

Curr HIV Res. 2009 Jul;7(4):454-61.PMID: 19601783 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.

Viljanen AP, Virtanen KA, Järvisalo MJ, Hällsten K, Parkkola R, Rönnemaa T, Lönnqvist F, Iozzo P, Ferrannini E, Nuutila P.

J Clin Endocrinol Metab. 2005 Dec;90(12):6523-8. Epub 2005 Sep 27.PMID: 16189256 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E.

Diabetes Care. 2004 Jun;27(6):1349-57.PMID: 15161787 [PubMed - indexed for MEDLINE]Related articlesFree article